Published on 11 Apr 2024 on Simply Wall St. via Yahoo Finance
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) is definitely on the radar of institutional investors who...
Key Insights
Given the large stake in the stock by institutions, Fusion Pharmaceuticals' stock price might be vulnerable to their trading decisionsA total of 10 investors have a majority stake in the company with 51% ownership Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business
Every investor in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) should be aware of the most powerful shareholder groups. With 46% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.